Immunologic adjuvant thio glycoside compounds and compositions
US4259324A · kind A · utility
10Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 31, 1979 |
| Grant date | Mar 31, 1981 |
| Priority date | — |
| Expiry date | Jul 31, 1999 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J17/005
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of the formulae Y--R wherein Y is 1-thio-.beta.-L-fucose, 1-thio-.beta.-D-galactose or 1-thio-.beta.-lactose and R is 2-(1-adamantyl)ethyl, 3-[(p-tetrafluorophenethyl)phenyl]propyl, 6-(5-cholesten-3.beta.-yloxy)hex-3-ynl, oleyl, or hexadecyl are useful immunologic adjuvants in vaccines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.